Dow Down0.17% Nasdaq Down0.28%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.11 Down 0.05(4.31%) Sep 30, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,846   15,289   323   323  
Cost of Revenue -   -   -   -  
Gross Profit 1,846   15,289   323   323  
Operating Expenses
Research Development9,300  11,767  11,889  19,414  
Selling General and Administrative4,845  5,555  4,499  4,440  
Non Recurring5,166  3,859  4  77  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (17,465) (5,892) (16,069) (23,608)
Income from Continuing Operations
Total Other Income/Expenses Net8  23  20  58  
Earnings Before Interest And Taxes(17,457)(5,869)(16,049)(23,550)
Interest Expense502  581  676  756  
Income Before Tax(17,959)(6,450)(16,725)(24,306)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(17,959)(6,450)(16,725)(24,306)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (17,959) (6,450) (16,725) (24,306)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (17,959) (6,450) (16,725) (24,306)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.